Abstract
There is abundant evidence that rheumatoid arthritis (RA), a chronic inflammatory disorder, is associated with an increased risk for cardiovascular (CV) disease. While there may be several mechanisms contributing to a higher CV risk in RA patients, inflammation is considered to be the main cause explaining the excess CV burden. Inflammatory processes appear pivotal to the atherothrombotic process and are linked to endothelial dysfunction, fatty streak initiation and progression, deterioration of fatty streaks into (unstable) plaques, and plaque rupture. Moreover, systemic inflammation, through tumor necrosis factor (TNF) or related cytokines, appears to accelerate atherothrombosis either directly or via effects on conventional and novel CV risk factors, such as lipids and lipoproteins, blood pressure, haemostatic factors, and insulin resistance. New and highly specific therapeutic agents (TNF inhibitors) may significantly lower CV risk in RA. This review summarizes the evidence base supporting the notion that TNF inhibitors confer benefit CV disease risk in RA.
Citations
May 8, 2013·Zeitschrift für Rheumatologie·H Pieringer, U C Hoppe
Jul 25, 2012·BMC Musculoskeletal Disorders·Aamer SandooGeorge D Kitas
Jul 17, 2013·The Pharmacogenomics Journal·J BluettA Barton
Apr 2, 2013·Autoimmunity Reviews·Theodoros DimitroulasGeorge D Kitas
May 2, 2014·BMC Musculoskeletal Disorders·Inger L MeekMart A F J van de Laar
Mar 4, 2014·Seminars in Arthritis and Rheumatism·Sophie MavrogeniGeorge D Kitas
Mar 7, 2013·Der Internist·E Decker, U Müller-Ladner
Feb 6, 2016·Mayo Clinic Proceedings·Mariana GarciaSharon L Mulvagh
Jun 16, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Paulo J C LinPieter R Cullis
Nov 28, 2015·Chinese Medical Journal·Yuan-Yuan CaoJun-Bo Ge
Apr 8, 2016·Rheumatology·Perle TotosonCéline Demougeot
Jul 24, 2012·Clinical Biochemistry·Aamer SandooGeorge D Kitas
Jun 22, 2013·Seminars in Arthritis and Rheumatism·Sophie MavrogeniGeorge D Kitas
Sep 13, 2014·Rheumatology·James BluettUNKNOWN BRAGGSS
Dec 24, 2014·Nature Reviews. Cardiology·Megha PrasadAmir Lerman
Dec 8, 2016·Expert Opinion on Drug Safety·Giuliano TocciRaffaele Scarpa
Mar 9, 2018·Rheumatology International·Sophie I MavrogeniGeorge D Kitas
Aug 2, 2013·Therapeutic Advances in Musculoskeletal Disease·Inge A M van den OeverMichael T Nurmohamed
Jul 24, 2013·Current Opinion in Allergy and Clinical Immunology·Valérie Gouilleux-GruartAlain Fischer
Oct 11, 2014·Clinical and Experimental Immunology·Y Chang, W Wei
Aug 9, 2018·Arthritis Research & Therapy·Joshua L LeeLyn March
Nov 10, 2020·Joint, Bone, Spine : Revue Du Rhumatisme·Ingrid VismanMichael Nurmohamed
May 22, 2021·Journal of Inflammation Research·George E FragoulisGeorge D Kitas